Glioma is a type of tumor that occurs in the brain and/or spinal cord that begins in the glial cells that surround nerve cells.
Glioma can affect your brain function and be life-threatening depending on their location and rate of growth. Approximately 18,500 people in the U.S. are diagnosed with a glioma each year.
Researchers have discovered through genetic testing of the tumor, they can accurately identify the sub-type of glioma. This testing:
Tests look for three specific mutations in the patient's DNA.
Depending on the combination of mutations, doctors can place a patient in one of 5 groups.
Choose the treatment that offers the best possible prognosis for each patient.
How it benefits the patient.
Source: "Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors," New England Journal of Medicine (June 2015), Mayo Clinic and the University of California, San Francisco; CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.